U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
© Reuters. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File PhotoDespite the FDA approval, Amgen's treatment is expected to be launched in 2025 as part of a legal settlement between the two companies earlier this year to delay the entry of the therapy.Stelara, introduced in 2009, has been J&J's top-selling drug since 2019, with sales reaching $9.7 billion in 2022.
{username} Just Now Share Follow this postUnfollow this post Save Saved. See Saved Items . This comment has already been saved in your Saved Items Author's response{commentContent} Reply 00 Report {username} Just NowAuthor's response Share Follow this postUnfollow this post Save Saved. See Saved Items .
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Amgen third-quarter sales rise 5%; profit up before chargeAmgen third-quarter sales rise 5%; profit up before charge
Lire la suite »
Amgen's stock hit by expectations its obesity pipeline is facing a longer waitAmgen said data from an early and mid-stage trial of obesity drugs will come in 2024
Lire la suite »
Amgen third-quarter sales rise 5%; profit up before chargeAmgen (AMGN.O), which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was offset by lower prices.
Lire la suite »
Amgen’s stock jumps premarket after earnings beat and company again raises guidanceCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Lire la suite »
Amgen Stock Jumps on Earnings Beat, Guidance BoostThe biotechnology company beat third-quarter adjusted earnings estimates but fell a bit short on sales.
Lire la suite »
Some Cold Medicines Don’t Work. Here’s What Doctors Recommend Instead.With FDA advisers determining that phenylephrine is ineffective, doctors and pharmacists recommend alternatives for congestion relief
Lire la suite »